The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ...

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy safe eye drops.

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer. BRS Analytical Service LLC has voluntarily recalled the items ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision loss in mice with an inherited eye disease. In mice both with retinitis ...